-
08:11:45 AM
Sign in with email
Forgot your password?
Register with email
Account Verification

ADTX - Aditxt Inc

09/09/21 8:26 AM
Nasdaq : ADTX
covid-19
Aditxt, Inc. and SphereDX Launch AditxtScore™ for COVID-19 in Kentucky, Ohio and Indiana to Address Individual Immune Status Uncertainty and Help Evaluate Cadence for Booster Shots
Aditxt, Inc., a biotech innovation company with a mission to improve the health of the immune system, today announced a partnership with SphereDX, an advanced clinical diagnostic lab focusing on next-generation genomic and metabolomic clinical testing, to offer its AditxtScore™ for COVID-19. Under the agreement, SphereDX will make...
RHEA-AI
neutral
09/07/21 9:15 AM
Nasdaq : ADTX
offeringacquisitioncovid-19
Aditxt Announces Closing of $11 Million Registered Direct Offering, and Funding of Bridge Loan Satisfying a Key Term of its Letter of Intent for Planned Acquisition of Commercial Stage Pharma Company with Anti-Viral COVID-19 Therapy
Aditxt, Inc., a biotech innovation company with a mission to improve the health of the immune system, today announced it has closed on a registered direct offering for $11 million announced on August 26, 2021 and funded a bridge loan to its acquisition target, satisfying a key term of the Letter of Intent. Aditxt is advancing its negotiations and due diligence...
RHEA-AI
positive
08/26/21 9:15 AM
Nasdaq : ADTX
offering
Aditxt Announces Pricing of $11.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Aditxt, Inc., a biotech innovation company with a mission to improve the health of the immune system, announced today that it has entered into definitive agreements with certain institutional investors to purchase 4,583,334 shares of its common stock at a purchase price of $2.40 per share in a registered direct offering priced at-the-market under Nasdaq...
RHEA-AI
neutral
08/25/21 9:16 AM
Nasdaq : ADTX
acquisitioncovid-19
Aditxt, Inc. Signs Letter of Intent for Exclusive Rights to Negotiate the Acquisition of a Biopharmaceutical Company Commercializing and Distributing Antiviral Oral Therapy for COVID-19
Aditxt, Inc., a biotech innovation company with a mission to improve the health of the immune system, today announced that it has signed a letter of intent to acquire a biopharmaceutical company, the“ Target Company”, commercializing COVID-19 antiviral oral therapy. Key terms of the proposed transaction as stated in the LOI include: the completion of a proposed...
RHEA-AI
very positive
08/11/21 8:00 AM
Nasdaq : ADTX
covid-19
Aditxt, Inc. and Great Lakes Medical Laboratory Launch AditxtScore for COVID-19 in State of Michigan as a Personalized Approach to Addressing COVID-19 Pandemic
Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced a partnership with Great Lakes Medical Laboratory, Inc. (GLML), a full-service medical reference laboratory, to offer its AditxtScore™ for COVID-19 throughout the
RHEA-AI
neutral